3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Gastrointestinal Stromal Tumors
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Burkitt Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Neoplasms
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Melanoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid
1
Leukemia, Biphenotypic, Acute
1
Hypereosinophilic Syndrome
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Digestive System Neoplasms
1
Congenital Bone Marrow Failure Syndromes
1
Blast Crisis
1
Interventions
darolutamide
2
olaparib
1
gedatolisib
1
gallium 68 PSMA-11
1
Radiotherapy
1
Pluvicto
1
Nivolumab
1
Lutetium-177
1
Lutetium
1
Cryotherapy
1
Brachytherapy
1
Androgen Antagonists
1
Abiraterone Acetate
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Diseases
×
Imatinib Mesylate
×
90 days
×
Clear all
No trials found.